(UEQ3) UBS (Irl) Fund Solutions – - Ratings and Ratios

Exchange: XETRA • Country: Germany • Currency: GBP • Type: Etf • ISIN: IE00B50XJX92

Description: UEQ3 UBS (Irl) Fund Solutions –

Additional Sources for UEQ3 ETF

Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

UEQ3 ETF Overview

Market Cap in USD 65m
Category Commodities - Broad Basket
TER 0.30%
IPO / Inception 2015-03-05

UEQ3 ETF Ratings

Growth Rating 67.6
Fundamental -
Dividend Rating 0.0
Rel. Strength 0.98
Analysts -
Fair Price Momentum 138.70 GBP
Fair Price DCF -

UEQ3 Dividends

Currently no dividends paid

UEQ3 Growth Ratios

Growth Correlation 3m 87%
Growth Correlation 12m 67%
Growth Correlation 5y 77.9%
CAGR 5y 13.64%
CAGR/Max DD 5y 0.67
Sharpe Ratio 12m 1.01
Alpha -4.46
Beta 0.259
Volatility 14.20%
Current Volume 0k
Average Volume 20d 0k
What is the price of UEQ3 shares?
As of July 06, 2025, the stock is trading at GBP 140.04 with a total of 4 shares traded.
Over the past week, the price has changed by +1.09%, over one month by +2.43%, over three months by +5.73% and over the past year by +0.76%.
Is UBS (Irl) Fund Solutions – a good stock to buy?
Yes. Based on ValueRay's Analyses, UBS (Irl) Fund Solutions – (XETRA:UEQ3) is currently (July 2025) a good stock to buy. It has a ValueRay Growth Rating of 67.56 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of UEQ3 is around 138.70 GBP . This means that UEQ3 is currently overvalued and has a potential downside of -0.96%.
Is UEQ3 a buy, sell or hold?
UBS (Irl) Fund Solutions – has no consensus analysts rating.
What are the forecasts for UEQ3 share price target?
According to our own proprietary Forecast Model, UEQ3 UBS (Irl) Fund Solutions – will be worth about 152.2 in July 2026. The stock is currently trading at 140.04. This means that the stock has a potential upside of +8.7%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 152.2 8.7%